Alzheimer’s is the most common cause of dementia, with more than 3 million cases in the United States a year. This progressive neurological disorder causes the brain to atrophy (shrink), leading to brain cell death. As a result, most individuals that suffer from Alzheimer’s experience memory loss, behavioral changes, and a decline in cognitive abilities, often interfering with daily life.
Researchers are unable to pinpoint a single cause of Alzheimer’s disease as it is believed the disease develops from a multitude of factors. These factors range from genetics, to lifestyle to environment with additional influence factors including age, family history, and heredity.
Although risk factors such as genes and age cannot be changed, growing evidence suggests that the adoption of lifestyle habits, ones that aim to reduce high blood pressure, improve diets, or the inclusion of exercise, can positively impact both the body and brain, thereby reducing, delaying or preventing Alzheimer’s symptoms.
Participating in Alzheimer’s and related dementia clinical trials is essential in progressing Alzheimer’s research, especially as the number of cases continues to exponentially grow. Advancements on improved treatments can only be done through human participants, with these studies having deeply influential and measurable impacts on current and future Alzheimer patients. Through these clinical trials, scientist and researchers are able to make tremendous strides on understanding the effects of Alzheimer’s on the brain, allowing us to develop and test promising new strategies for treatment, prevention, diagnosis, and ultimately, a cure for Alzheimer’s disease
For those interested in participating, Voyage Medical is conducting life-changing Alzheimers and dementia clinical trials. Please contact us at (480) 306-5000 or visit our Join A Study page at VoyageMedical.com to enroll, helping us take one step closer to an Alzheimers-free future.
